Genomic instability |
The major cause of neoplasia, cancer initiation, progression, and impact the overall prognosis of the affected lung cancer patient |
[41] |
Inhibition of telomerase activity |
Chromosome destabilization causes cellular senescence and death; in lung cancer telomere dysfunction promotes progression, metastasis and was associated with poor prognosis |
[42,43] |
Epigenetic mechanisms: (DNA hypermethylation, altered chromatin remodeling and histone modifications) |
Established during differentiation, stably inherited and maintained through multiple rounds of cell division; deregulation of miRNAs is associated with early recurrence of lung cancer lesions |
[42,44] |
Mitochondrial DNA alteration |
Plays a pivotal role in tumorigenesis; evasion of apoptosis |
[42,45] |
Intercellular communication |
establishes a distinct tumor microenvironment (TME) with various stromal cell types to support growth, angiogenesis and invasion; altered communication of tumor cells to immune cells enable immune surveillance |
[46] |
Extracellular matrix (ECM) dysregulation |
ECM actively undergoes dynamic remodeling during all stages of cancer progression; crosstalk between tumor cells and immune cells within primary and secondary sites is fundamental to ECM remodeling that feeds back to regulate tumor cell dormancy and outgrowth |
[47] |
Stem cell exhaustion |
Cancer and aging are two possible endpoints of stem cells exposed to mutagenic hits, which will cause cell cycle arrest, and apoptosis or senescence. Through the acquisition of mutation and genetic or epigenetic alterations, normal stem cells can become CSCs |
[48,49] |